Paolo Cavazza, 10% Owner at SCICLONE PHARMACEUTICALS INC (SCLN), bought 28,600 shares at $2.05 ($59K) on 2008-01-30, disclosed to the SEC on 2008-02-01.
Open-market purchase of $59k SCLN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| SNGX | SELL | 2017-12-01 | $1.2M | — | Filing → |
| SCLN | SELL | 2012-05-02 | $33.2M | — | Filing → |
| RGRX.OB | BUY | 2011-01-07 | $600K | — | Filing → |